PropertyValue
?:definition
  • Administration of a medicinal product by an unspecified route, including administration to the skin or to a mucous membrane, and excluding oral and parenteral administration. This term is only to be used where a single specific route of administration (e.g. \'Cutaneous use\') cannot be identified. Comment: This term is not intended to describe an authorised route of administration for use in marketing authorisations. It is intended for use in adverse event reporting for pharmacovigilance purposes where more-specific information on the route of administration is not available.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C1522168_NCI_EDQM-HC>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C1522168_NCI_EDQM-HC>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all